Back to 
Royal Bank of Canada
Royal Bank of Canada
NAGE
Showing 8 of 28 quarters
Position history for Royal Bank of Canada's holdings in Niagen Bioscience, Inc.
Yes. Royal Bank of Canada holds 247,063 shares of NAGE (Niagen Bioscience), worth $788,000, as of its Q2 2026 13F filing. It increased the position by 121,758 shares (+97.2%) from Q1 2026. Royal Bank of Canada has held NAGE since Q3 2022, across 16 quarterly 13F filings.
Current Value
$788,000
Current Shares
247,063
Total Value Change
+$55,000
Total Shares Change
+46,303
Quarter-by-Quarter History
Other major holders of NAGE: Vanguard Group Inc., BlackRock, Inc.